To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.

H.R. 7391 of the 119th Congress, introduced on February 5, 2026, seeks to amend title III of the Public Health Service Act. The bill aims to prevent Federally-qualified health centers from being obligated to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.